litlas
ログインアカウント作成

Richard Aplenc

2001–2025 年に発表

111
論文数
19,302
被引用数
60
h 指数
100
i10 指数

被引用数

Richard Aplenc の年別被引用数1991 年: 被引用 3 件1994 年: 被引用 1 件1997 年: 被引用 1 件2001 年: 被引用 6 件2002 年: 被引用 5 件2003 年: 被引用 7 件2004 年: 被引用 5 件2005 年: 被引用 11 件2006 年: 被引用 20 件2007 年: 被引用 19 件2008 年: 被引用 19 件2009 年: 被引用 28 件2010 年: 被引用 23 件2011 年: 被引用 28 件2012 年: 被引用 39 件2013 年: 被引用 93 件2014 年: 被引用 126 件2015 年: 被引用 272 件2016 年: 被引用 312 件2017 年: 被引用 375 件2018 年: 被引用 438 件2019 年: 被引用 925 件2020 年: 被引用 1,117 件2021 年: 被引用 1,047 件2022 年: 被引用 833 件2023 年: 被引用 705 件2024 年: 被引用 933 件2025 年: 被引用 507 件2026 年: 被引用 11 件1992〜1993 年は被引用が無いため表示していません1995〜1996 年は被引用が無いため表示していません1998〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,203 件、この内訳の 33%中国: 引用元論文 1,117 件、この内訳の 11.5%ドイツ: 引用元論文 626 件、この内訳の 6.4%イギリス: 引用元論文 489 件、この内訳の 5%イタリア: 引用元論文 406 件、この内訳の 4.2%カナダ: 引用元論文 334 件、この内訳の 3.4%フランス: 引用元論文 301 件、この内訳の 3.1%オランダ: 引用元論文 277 件、この内訳の 2.9%スペイン: 引用元論文 253 件、この内訳の 2.6%スイス: 引用元論文 236 件、この内訳の 2.4%オーストラリア: 引用元論文 226 件、この内訳の 2.3%日本: 引用元論文 220 件、この内訳の 2.3%
0%33%その他 20.9%

機関

分野

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology9%
  • Immunology and Microbiology4.4%
  • Engineering0.9%
  • Neuroscience0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • その他1.1%

トピック

  • CAR-T cell therapy research19.9%
  • Virus-based gene therapy research5.5%
  • Immune Cell Function and Interaction5.4%
  • Acute Lymphoblastic Leukemia research4.2%
  • Nanowire Synthesis and Applications4.1%
  • Immunotherapy and Immune Responses3.8%
  • その他57.1%

共著者

全論文

検索で開く
  1. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

    著者: Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, Richard Aplenc, David M. Barrett, Nancy Bunin, Anne Chew, Vanessa Gonzalez, Zhaohui Zheng, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Susan R. Rheingold, Angela Shen, David T. Teachey, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp - New England Journal of Medicine 2014 被引用: 5,408

  2. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

    著者: Stephan A. Grupp, Michael Kalos, David M. Barrett, Richard Aplenc, David L. Porter, Susan R. Rheingold, David T. Teachey, Anne Chew, Bernd Hauck, J. Fraser Wright, Michael C. Milone, Bruce L. Levine, Carl H. June - New England Journal of Medicine 2013 被引用: 3,491

  3. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

    著者: David T. Teachey, Simon F. Lacey, Pamela A. Shaw, J. Joseph Melenhorst, Shannon L. Maude, Noelle V. Frey, Edward Pequignot, Vanessa Gonzalez, Fang Chen, Jeffrey Finklestein, David M. Barrett, Scott L. Weiss, Julie C. Fitzgerald, Robert A. Berg, Richard Aplenc, Colleen Callahan, Susan R. Rheingold, Zhaohui Zheng, Stefan Rose‐John, Jason C. White, Farzana Nazimuddin, Gerald Wertheim, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp - Cancer Discovery 2016 被引用: 1,084

  4. Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy

    著者: Pablo García‐Pavía, Yuri Kim, María Alejandra Restrepo-Córdoba, Ida G. Lunde, Hiroko Wakimoto, Amanda M. Smith, Christopher N. Toepfer, Kelly Getz, Joshua Gorham, Parth Patel, Kaoru Ito, Jon A. L. Willcox, Zoltàn Arany, Jian Li, Anjali Owens, Risha Govind, Beatriz Núñez, Erica Mazaika, Antoni Bayés‐Genís, Roddy Walsh, Brian S. Finkelman, Josep Lupón, Nicola Whiffin, Isabel Serrano, William Midwinter, Alicja Wilk, Alfredo Bardajı́, Nathan Ingold, Rachel Buchan, Upasana Tayal, Domingo A. Pascual‐Figal, Antonio de Marvao, Mian Ahmad, José Manuel García‐Pinilla, Antonis Pantazis, Fernándo Domínguez, A. John Baksi, Declan P. O’Regan, Stuart D. Rosen, Sanjay Prasad, Enrique Lara‐Pezzi, Mariano Provencio, Alexander R. Lyon, Luis Alonso‐Pulpón, Stuart A. Cook, Steven R. DePalma, Paul J.R. Barton, Richard Aplenc, Jonathan G. Seidman, Bonnie Ky, James S. Ware, Christine E. Seidman - Circulation 2019 被引用: 344

  5. Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

    著者: Stephan Kadauke, Regina M. Myers, Yimei Li, Richard Aplenc, Diane Baniewicz, David M. Barrett, Allison Barz Leahy, Colleen Callahan, J. Gregory Dolan, Julie C. Fitzgerald, Whitney L. Gladney, Simon F. Lacey, Hongyan Liu, Shannon L. Maude, Regina McGuire, Laura Motley, David T. Teachey, Gerald Wertheim, Lisa Wray, Amanda M. DiNofia, Stephan A. Grupp - Journal of Clinical Oncology 2021 被引用: 212

  6. Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

    著者: Regina M. Myers, Yimei Li, Allison Barz Leahy, David M. Barrett, David T. Teachey, Colleen Callahan, Christina Fasano, Susan R. Rheingold, Amanda M. DiNofia, Lisa Wray, Richard Aplenc, Diane Baniewicz, Hongyan Liu, Pamela A. Shaw, Edward Pequignot, Kelly Getz, Jennifer L. Brogdon, Andrew D. Fesnak, Donald L. Siegel, Megan M. Davis, Chelsie Bartoszek, Simon F. Lacey, Elizabeth O. Hexner, Anne Chew, Gerald Wertheim, Bruce L. Levine, Carl H. June, Stephan A. Grupp, Shannon L. Maude - Journal of Clinical Oncology 2021 被引用: 187

  7. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

    著者: David T. Teachey, Susan R. Rheingold, Shannon L. Maude, Gerhard Zugmaier, David M. Barrett, Alix E. Seif, Kim E. Nichols, Erica Suppa, Michael Kalos, Robert A. Berg, Julie C. Fitzgerald, Richard Aplenc, Lia Gore, Stephan A. Grupp - Blood 2013 被引用: 617

  8. CD38 as a pan-hematologic target for chimeric antigen receptor T cells

    著者: Tina Glisovic‐Aplenc, Caroline Diorio, John Chukinas, Kimberly Veliz, Olga Shestova, Feng Shen, Selene Nuñez-Cruz, Tiffaney L. Vincent, Fei Miao, Michael C. Milone, Carl H. June, David T. Teachey, Sarah K. Tasian, Richard Aplenc, Saar Gill - Blood Advances 2023 被引用: 60

  9. CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials

    著者: Allison Barz Leahy, Haley Newman, Yimei Li, Hongyan Liu, Regina M. Myers, Amanda M. DiNofia, J. Gregory Dolan, Colleen Callahan, Diane Baniewicz, Kaitlin J. Devine, Lisa Wray, Richard Aplenc, Carl H. June, Stephan A. Grupp, Susan R. Rheingold, Shannon L. Maude - The Lancet Haematology 2021 被引用: 120

  10. Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

    著者: Caroline Diorio, Rawan Shraim, Regina M. Myers, Edward M. Behrens, Scott Canna, Hamid Bassiri, Richard Aplenc, Chakkapong Burudpakdee, Fang Chen, Amanda M. DiNofia, Saar Gill, Vanessa Gonzalez, Michele P. Lambert, Allison Barz Leahy, Bruce L. Levine, Robert B. Lindell, Shannon L. Maude, J. Joseph Melenhorst, Haley Newman, Jessica Perazzelli, Alix E. Seif, Simon F. Lacey, Carl H. June, David M. Barrett, Stephan A. Grupp, David T. Teachey - Clinical Cancer Research 2022 被引用: 65

  11. Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

    著者: Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi, Lillian Sung, Robert B. Gerbing, Susana C. Raimondi, Betsy Hirsch, Samir B. Kahwash, Amy Heerema‐McKenney, Laura Winter, Kathleen Glick, Stella M. Davies, Patti Byron, Franklin O. Smith, Richard Aplenc - Journal of Clinical Oncology 2014 被引用: 472

  12. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A -Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531

    著者: Jessica A. Pollard, Erin Guest, Todd A. Alonzo, Robert B. Gerbing, Mike R. Loken, Lisa Eidenschink Brodersen, E. Anders Kolb, Richard Aplenc, Soheil Meshinchi, Susana C. Raimondi, Betsy Hirsch, Alan S. Gamis - Journal of Clinical Oncology 2021 被引用: 112

  13. Cytokine-mediated CAR T therapy resistance in AML

    著者: Anand Bhagwat, Leonel Torres, Olga Shestova, Maksim Shestov, Patrick Mellors, Han R Fisher, Saamia Farooki, Benjamin F. Frost, Michael R. Loken, Avery L. Gaymon, Diane Frazee, Walter Rogal, Noelle V. Frey, Elizabeth O. Hexner, Selina M. Luger, Alison W. Loren, Mary Ellen Martin, Shannon R. McCurdy, Alexander E. Perl, Edward A. Stadtmauer, Jennifer L. Brogdon, Joseph A. Fraietta, Wei‐Ting Hwang, Don L. Siegel, Gabriela Plesa, Richard Aplenc, David L. Porter, Carl H. June, Saar Gill - Nature Medicine 2024 被引用: 81

  14. CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial

    著者: Nirali N. Shah, Sarah K. Tasian, M. Eric Kohler, Emily M. Hsieh, Susanne H.C. Baumeister, Corinne Summers, Haneen Shalabi, Jessica A. Pollard, Bonnie Yates, Ruta Brazauskas, Eric Ndifon, Constance M. Yuan, Hao‐Wei Wang, Hati Kobusingye, Kayla Christianson, Allison A Weiss, Erin Leckrone, Bronwen E. Shaw, Jeffery J. Auletta, Hemalatha G. Rangarajan, John Roach, Julie Blake, Dennis F. Michiel, Brian Bowser, Sheryl Ruppel, George Mitra, Anthony Welch, Jason L. Yovandich, Rachelle Salomon, Leslie S. Kean, Katherine Tarlock, Michael A. Pulsipher, Michael R. Verneris, Larisa Broglie, Terry J. Fry, Steven M. Devine, Richard Aplenc - Blood 2023 被引用: 57

  15. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia

    著者: Eline J.M. Bertrums, Jenny L. Smith, Lauren Harmon, Rhonda E. Ries, Yi-Cheng J. Wang, Todd A. Alonzo, Andrew J. Menssen, Karen M. Chisholm, Amanda R. Leonti, Katherine Tarlock, Fabiana Ostronoff, Era L. Pogosova‐Agadjanyan, Gertjan J.L. Kaspers, Henrik Hasle, Michael Dworzak, Christiane Walter, Nora Mühlegger, Cristina Morerio, Laura Pardo, Betsy Hirsch, Susana C. Raimondi, Todd M. Cooper, Richard Aplenc, Alan S. Gamis, E. Anders Kolb, Jason E. Farrar, Derek L. Stirewalt, Xiaotu Ma, Timothy I. Shaw, Scott N. Furlan, Lisa Eidenschink Brodersen, Michael R. Loken, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Timothy J. Triche, Bianca F. Goemans, Soheil Meshinchi - Haematologica 2023 被引用: 71

  16. Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031

    著者: Jessica A. Pollard, Todd A. Alonzo, Robert Gerbing, Patrick Brown, Elizabeth Fox, John Choi, Brian Fisher, Betsy Hirsch, Samir Kahwash, Kelly Getz, John Levine, Lisa Eidenschink Brodersen, Michael R. Loken, Susana Raimondi, Katherine Tarlock, Andrew Wood, Lillian Sung, E. Anders Kolb, Alan Gamis, Soheil Meshinchi, Richard Aplenc - Journal of Clinical Oncology 2022 被引用: 101

  17. Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies

    著者: Julie K. Jadlowsky, Elizabeth O. Hexner, Amy Marshall, Stephan A. Grupp, Noelle V. Frey, James L. Riley, Elizabeth Veloso, Holly McConville, Walter Rogal, Cory Czuczman, Wei‐Ting Hwang, Yimei Li, Rachel Leskowitz, Olivia Farrelly, Jayashree Karar, Shannon Christensen, Julie S. Barber-Rotenberg, Avery L. Gaymon, Naomi Aronson, Wendy Bernstein, J. Joseph Melenhorst, Aoife M. Roche, J.K. Everett, Sonja A. Zolnoski, Alexander McFarland, Shantan Reddy, Angelina Petrichenko, Emma J. Cook, Carole Lee, Vanessa Gonzalez, Kathleen A. Alexander, Irina Kulikovskaya, Ángel Ramírez-Fernández, Janna Minehart, Marco Ruella, Saar Gill, Stephen J. Schuster, Adam D. Cohen, Alfred L. Garfall, Payal D. Shah, David L. Porter, Shannon L. Maude, Bruce L. Levine, Don L. Siegel, Anne Chew, S.J. McKenna, Lester Lledo, Megan M. Davis, Gabriela Plesa, Friederike Herbst, Edward A. Stadtmauer, Pablo Tebas, Amanda M. DiNofia, A. Haas, Naomi B. Haas, Regina M. Myers, Donald M. O’Rourke, Jakub Svoboda, János L. Tanyi, Richard Aplenc, Jeffrey M. Jacobson, Andrew H. Ko, Roger B. Cohen, Carl H. June, Frederic D. Bushman, Joseph A. Fraietta - Nature Medicine 2025 被引用: 71

  18. Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia

    著者: Karen L. Bride, Tiffaney L. Vincent, Soo-Yeon Im, Richard Aplenc, David M. Barrett, William L. Carroll, Robin Carson, Yunfeng Dai, Meenakshi Devidas, Kimberly P. Dunsmore, Tori J. Fuller, Tina Glisovic‐Aplenc, Terzah M. Horton, Stephen P. Hunger, Mignon L. Loh, Shannon L. Maude, Elizabeth A. Raetz, Stuart S. Winter, Stephan A. Grupp, Michelle L. Hermiston, Brent L. Wood, David T. Teachey - Blood 2018 被引用: 227

  19. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer

    著者: Eric J. Chow, Sanjeev Aggarwal, David R. Doody, Richard Aplenc, Saro H. Armenian, K. Scott Baker, Smita Bhatia, Nancy Blythe, Steven D. Colan, Louis S. Constine, David R. Freyer, Lisa M. Kopp, Caroline Laverdière, Wendy M. Leisenring, Nao Sasaki, Lynda M. Vrooman, Barbara L. Asselin, Cindy L. Schwartz, Steven E. Lipshultz - Journal of Clinical Oncology 2023 被引用: 74

  20. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

    著者: C. Michel Zwaan, E. Anders Kolb, Dirk Reinhardt, Jonas Abrahamsson, Souichi Adachi, Richard Aplenc, Eveline S.J.M. de Bont, Barbara De Moerloose, Michael Dworzak, Brenda Gibson, Henrik Hasle, Guy Leverger, Franco Locatelli, Christine Ragu, Raul C. Ribeiro, Carmelo Rizzari, Jeffrey E. Rubnitz, Owen Smith, Lillian Sung, Daisuke Tomizawa, Marry M. van den Heuvel‐Eibrink, Ursula Creutzig, Gertjan J.L. Kaspers - Journal of Clinical Oncology 2015 被引用: 383

  21. CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

    著者: Katherine Tarlock, Adam J. Lamble, Yi‐Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, Michael R. Loken, Lisa Eidenschink Brodersen, Laura Pardo, Amanda R. Leonti, Jenny L. Smith, Tiffany A. Hylkema, William G. Woods, Todd M. Cooper, E. Anders Kolb, Alan S. Gamis, Richard Aplenc, Todd A. Alonzo, Soheil Meshinchi - Blood 2021 被引用: 120

  22. Characteristics and prognostic impact ofIDHmutations in AML: a COG, SWOG, and ECOG analysis

    著者: Sara Zarnegar‐Lumley, Todd A. Alonzo, Robert B. Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E. Ries, Jim J. Wang, Amanda R. Leonti, Matthew A. Kutny, Fabiana Ostronoff, Jerald P. Radich, Frederick R. Appelbaum, Era L. Pogosova‐Agadjanyan, Kristen M. O’Dwyer, Martin S. Tallman, Mark R. Litzow, Ehab Atallah, Todd M. Cooper, Richard Aplenc, Omar Abdel‐Wahab, Alan S. Gamis, Selina M. Luger, Harry P. Erba, Ross L. Levine, E. Anders Kolb, Derek L. Stirewalt, Soheil Meshinchi, Katherine Tarlock - Blood Advances 2023 被引用: 58

  23. Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials

    著者: Sumit Gupta, Yunfeng Dai, Zhiguo Chen, Lena E. Winestone, David T. Teachey, Kira Bona, Richard Aplenc, Karen R. Rabin, Patrick A. Zweidler‐McKay, Andrew J. Carroll, Nyla A. Heerema, Julie M. Gastier‐Foster, Michael J. Borowitz, Brent L. Wood, Kelly W. Maloney, Leonard A. Mattano, Eric Larsen, Anne Angiolillo, Michael J. Burke, Wanda L. Salzer, Stuart S. Winter, Patrick A. Brown, Erin Guest, Kimberley P Dunsmore, John A. Kairalla, Naomi Winick, William L. Carroll, Elizabeth A. Raetz, Stephen P. Hunger, Mignon L. Loh, Meenakshi Devidas - The Lancet Haematology 2023 被引用: 66

  24. Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group

    著者: Richard Aplenc, Soheil Meshinchi, Lillian Sung, Todd A. Alonzo, John Choi, Brian T. Fisher, Robert B. Gerbing, Betsy Hirsch, Terzah M. Horton, Samir B. Kahwash, John E. Levine, Michael R. Loken, Lisa Eidenschink Brodersen, Jessica A. Pollard, Susana C. Raimondi, E. Anders Kolb, Alan S. Gamis - Haematologica 2020 被引用: 169